MedPath

To evaluate effect of daruharidra arka in the management of dry eye syndrome

Phase 3
Conditions
Health Condition 1: H048- Other disorders of lacrimal system
Registration Number
CTRI/2024/07/071502
Lead Sponsor
Dr Vignesh Sen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patient having specific symptoms of Dry eye.

2.Schirmer-I test positive (less than 15mm)

3.Tear film break-up time less than 15 seconds

Exclusion Criteria

1.Patient with impaired eyelid function (eg: Bell’s palsy)

2.Patients with eyelid deformities

3.Patients with infective eye disease

4.Pregnancy, lactation, patients under corticosteroids

5.Patients on steroids, oral contraceptive pills, estrogen replacement therapy or any other medication that may adversely affect the outcome of the study

6.Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho-Neuro- Endocrinal disorders, etc.).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath